Testosterone In Women: How It Affects Menopause And Libido

Testosterone therapy may improve sex drive in postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD), a condition defined by persistent low desire that causes personal distress. A meta-analysis of 36 randomized controlled trials with 8,480 participants found that transdermal testosterone was associated with improvements in desire, arousal, orgasm, and frequency of satisfying sexual episodes (Islam et al., 2019). Long-term safety data beyond two to three years remain limited, and side effects do occur.

Clinicians who specialize in women's hormone health recommend blood work and a full clinical evaluation before prescribing testosterone. Not every case of low libido after menopause points to a hormone problem, and ruling out other causes comes first.

Testosterone Levels During Menopause

Women produce roughly three times more testosterone than estrogen before menopause (Scott & Newson, 2020). Levels decline gradually with age, starting in the early 30s, and drop sharply after surgical removal of the ovaries. By late menopause, circulating testosterone can be considerably lower than peak reproductive levels, though the degree of decline varies among individuals.

Both natural and surgical menopause can contribute to symptoms associated with HSDD. No specific testosterone threshold reliably predicts which women will develop low desire, which is part of why blood levels alone don't confirm or rule out the diagnosis.

How Is HSDD Diagnosed?

HSDD is not simply low desire. The diagnosis requires persistent, distressing reduction in sexual interest that isn't explained by another medical condition, medication, or relationship issue. Standardized tools like the Decreased Sexual Desire Screener (DSDS) and the Female Sexual Function Index (FSFI) help separate HSDD from the normal fluctuations that accompany menopause.

A provider will review medication lists, screen for depression and thyroid dysfunction, and assess relationship factors before making the diagnosis. This step matters because testosterone is unlikely to address a problem that isn't hormonal.

What Treatments Come Before Testosterone?

Most providers start with low-dose estrogen, sex therapy, or certain medications. The 2019 Global Consensus Statement, endorsed by 11 international medical societies, recommends testosterone only for postmenopausal HSDD when other hormonal approaches have not worked (Davis et al., 2019). Cognitive behavioral therapy and mindfulness-based programs may also help improve desire, and some providers combine these with hormonal treatment.

Who Should Avoid Testosterone Therapy?

Women with cardiovascular disease, liver disease, or a history of breast or uterine cancer are generally advised against testosterone. Limited long-term research is the main reason for caution. A personalized hormone panel, combined with clinical evaluation, can help determine whether testosterone may be appropriate.

Women with polycystic ovary syndrome (PCOS) who already have elevated androgens may not be appropriate candidates. Testosterone is contraindicated during pregnancy and breastfeeding due to the risk of fetal harm.

Prescribing Testosterone for Women

No testosterone product carries FDA approval for women. Providers prescribe it off-label as transdermal creams or gels applied to the skin at roughly one-tenth the male dose. The ISSWSH clinical guideline recommends physiologic female doses and discontinuation after six months if there is no response (Parish et al., 2021).

In one of the largest clinical trials on this topic, 814 postmenopausal women receiving a 300 mcg/day testosterone patch reported a mean increase of 2.1 satisfying sexual episodes per 4-week period, compared with 0.7 for placebo (P<0.001) (Davis et al., 2008). Pellets and oral formulations are not recommended by current guidelines because of inconsistent dosing and liver metabolism concerns.

Side Effects of Testosterone in Women

Reported effects include acne, increased body or facial hair, scalp hair thinning, and weight changes. Voice deepening and clitoral enlargement are rare at physiologic doses and more common with supraphysiologic exposure. Across multiple trials lasting up to two years, transdermal testosterone at recommended doses showed no increase in serious adverse events compared to placebo, though long-term data remain limited (Islam et al., 2019).

Monitoring during treatment typically includes periodic blood work to assess safety and response.

Other Factors Behind Low Libido

Low sex drive during the menopausal transition rarely has a single cause. Vaginal dryness, medication side effects, thyroid imbalances, chronic conditions, stress, and relationship concerns all contribute. SSRIs and SNRIs, commonly prescribed for mood disorders, are among the most frequent medication-related contributors.

A combination of counseling, lifestyle changes, and medical treatment often produces better outcomes than any single approach. Addressing sleep, exercise, and relationship satisfaction before or alongside hormone therapy tends to improve results for women dealing with testosterone changes during menopause and libido concerns.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

Does testosterone increase sex drive during menopause?

Transdermal testosterone has been associated with improved sexual desire in postmenopausal women diagnosed with HSDD. A 2019 meta-analysis of 36 randomized controlled trials and 8,480 participants reported improvements in desire, arousal, and frequency of satisfying sexual episodes.

Is testosterone therapy FDA-approved for women?

No testosterone product is currently FDA-approved for women. Providers prescribe it off-label when clinically appropriate, typically as a transdermal cream or gel at doses formulated for the female physiologic range.

What are the side effects of testosterone in women?

Common side effects include acne and increased body or facial hair growth. At physiologic doses, serious effects like voice deepening and clitoral enlargement are rare. In trials lasting up to two years, transdermal delivery at recommended doses has not been linked to an increase in serious adverse events, though long-term data remain limited.

How long does testosterone therapy take to work in women?

Some women may notice changes within a few weeks, though it can take up to three to six months. Clinical guidelines recommend discontinuing treatment after six months if no improvement occurs.

Can women with a history of breast cancer use testosterone?

Testosterone is generally not recommended for women with a history of hormone-sensitive cancers, including breast or uterine cancer. Limited long-term safety data is the primary concern, and this decision should involve an oncologist and a thorough discussion of individual risks and benefits.

What is HSDD and how is it diagnosed?

Hypoactive sexual desire disorder (HSDD) is a persistent, distressing reduction in sexual interest not explained by another condition, medication, or relationship issue. Providers use standardized screening tools and clinical evaluation to distinguish HSDD from normal libido changes during menopause.

What other treatments help low libido after menopause?

Options include low-dose estrogen therapy, sex therapy, and certain medications. Many providers also address contributing factors like vaginal dryness, thyroid disorders, stress, and relationship concerns. A combination of approaches often produces better results than any single treatment.

References

• Lancet Diabetes Endocrinol. 2019;7(10):754-766

• Br J Gen Pract. 2020;70(693):203-204

• J Clin Endocrinol Metab. 2019;104(10):4660-4666

• J Sex Med. 2021;18(5):849-867

• N Engl J Med. 2008;359(19):2005-2017